Compounds > losartan

losartan and mocetinostat

losartan has been researched along with mocetinostat in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Alvarez, C; Geffner, JR; Giordano, M; Nahmod, K; Nahmod, V; Pereira, Y; Raiden, S; Semeniuk, G1
Inenaga, T; Kawano, Y; Nakahama, H; Nakamura, S; Sasaki, O; Ueda, H; Yoshihara, F1
Barros, LF; Becker, C; Carvalho, MH; de Gusmão, FM1
Chan, YC; Leung, PS1
Deng, H; Li, YP; Su, N; Wang, YN1
Feng, D; Li, K; Wang, L; Wu, Q; Yao, S1
Loke, WK; Ng, ET; Sim, MK1
Deng, J; Deng, W; Deng, Y; Wang, DX; Zhang, T1
Akershoek, JJ; Beelen, RHJ; Boekema, BKHL; Brouwer, KM; Middelkoop, E; Ulrich, MMW; Vlig, M1

Other Studies

10 other study(ies) available for losartan and mocetinostat

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bordetella bronchiseptica; Bordetella Infections; Calcium; Kinetics; Losartan; Lung; Male; Neutrophils; Oxygen; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Respiratory Distress Syndrome

2002
A favourable outcome using oral prednisolone and losartan only in a patient with ANCA-related glomerulonephritis: a discrepancy between histological activity and MPO-ANCA.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:3

    Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Drug Therapy, Combination; Humans; Losartan; Male; Nephrosis, Lipoid; Outcome Assessment, Health Care; Peroxidase; Prednisolone

2003
Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction.
    International journal of cardiology, 2005, Apr-28, Volume: 100, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dogs; Hemodynamics; Losartan; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Peroxidase; Stroke Volume

2005
AT1 receptor antagonism ameliorates acute pancreatitis-associated pulmonary injury.
    Regulatory peptides, 2006, Mar-15, Volume: 134, Issue:1

    Topics: alpha-Amylases; Angiotensin II Type 1 Receptor Blockers; Animals; Capillary Permeability; Ceruletide; Losartan; Lung; Lung Diseases; Male; Organ Size; Pancreas; Pancreatitis; Peroxidase; Rats; Receptor, Angiotensin, Type 1

2006
[Protective effect of losartan on endothelial cells exposed to high glucose levels in vitro].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2006, Volume: 35, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Cells, Cultured; Endothelium, Vascular; Glucose; Humans; Losartan; Peroxidase; RNA, Messenger; Superoxide Dismutase; Umbilical Veins; Vascular Endothelial Growth Factors

2006
Losartan attenuates ventilator-induced lung injury.
    The Journal of surgical research, 2008, Volume: 145, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Losartan; Lung; Male; Neutrophil Infiltration; Peroxidase; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Respiration, Artificial; Respiratory Distress Syndrome; RNA, Messenger

2008
Protective actions of des-aspartate-angiotensin I in mice model of CEES-induced lung intoxication.
    Journal of applied toxicology : JAT, 2011, Volume: 31, Issue:6

    Topics: Angiotensin I; Animals; Bronchoalveolar Lavage Fluid; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Epoprostenol; Intercellular Adhesion Molecule-1; Losartan; Lung; Male; Mice; Mice, Inbred BALB C; Mustard Gas; NADPH Oxidases; Peroxidase; Reactive Oxygen Species; Receptors, Immunologic; Signal Transduction

2011
Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cytoprotection; Disease Models, Animal; Down-Regulation; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Losartan; Lung; Lung Injury; Male; Neutrophil Infiltration; Peroxidase; Pulmonary Edema; Rats, Sprague-Dawley; Scavenger Receptors, Class E; Signal Transduction; Tumor Necrosis Factor-alpha

2015
Differential effects of Losartan and Atorvastatin in partial and full thickness burn wounds.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Actins; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Atorvastatin; Burns; Cicatrix; Combined Modality Therapy; Drug Therapy, Combination; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Losartan; Muscle, Smooth; Neutrophils; Peroxidase; Skin Transplantation; Swine; Time Factors; Transplantation, Autologous; Treatment Outcome; Wound Healing

2017